GlassScriptPhysician profile
Farhat Khairallah
NPI 1982603965
$179,240.43
in general payments reported to CMS, 2019-2025
32 companies · $106K in 2025
The $106K reported for 2025 was more than what 98% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $2,474 · 2021: $6,506 · 2022: $1,500 · 2023: $12K · 2024: $36K · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100K · Consulting Fee: $34K · Food and Beverage: $11K · Travel and Lodging: $8,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100,000.00 |
| Consulting Fee | $33,783.90 |
| Food and Beverage | $11,414.28 |
| Travel and Lodging | $8,623.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $158,278.25 | 2019-2025 | General - Ep, Farapulse, Rhythmia Mapping System |
| Abbott Laboratories | $8,169.88 | 2019-2025 | Aveir, Ensite, Accent |
| Ethicon US, LLC | $4,530.14 | 2021-2025 | Vistaseal, Dermabond, Dermabond Prineo |
| Medtronic, INC. | $3,359.14 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $776.93 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $477.62 | 2019-2024 | Camzyos, Eliquis |
| Penumbra, INC. | $416.64 | 2025 | Penumbra System, Indigo System |
| Cardiva Medical, INC. | $294.61 | 2023-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $288.17 | 2025 | Assure Wcd |
| Philips North America LLC | $265.86 | 2019-2025 | Igt Devices Undivided, Ambulatory Monitoring & Diagnostics Undivided, Trillium Cushions |
| Pfizer INC. | $248.90 | 2019-2024 | |
| Elutia, INC. | $243.11 | 2019-2024 | Ecm Patch,Pouch |
| Biosense Webster, INC. | $226.09 | 2024-2025 | Carto 3 |
| Cvrx, INC. | $198.35 | 2024-2025 | Barostim Neo System |
| Biotronik INC. | $190.51 | 2019-2023 | Biomonitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.29 | 2019-2025 | Lifevest |
| Medical Device Business Services, INC. | $172.49 | 2025 | Vistaseal |
| Bard Peripheral Vascular, INC. | $162.43 | 2020-2021 | |
| Amgen INC. | $141.07 | 2019-2023 | Repatha |
| Shockwave Medical, INC | $112.35 | 2025 | |
| Inari Medical, INC. | $108.19 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $103.34 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $90.84 | 2022-2025 | Verquvo |
| Zimmer Biomet Holdings, INC. | $54.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $44.43 | 2019-2024 | |
| Atricure, INC. | $18.82 | 2023 | |
| Silk Road Medical, INC. | $16.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Angiodynamics, INC. | $16.63 | 2021 | |
| Cardiovascular Systems INC. | $14.55 | 2019 | |
| Altathera Pharmaceuticals LLC | $12.84 | 2024 | Sotalol Hydrochloride |
| Astrazeneca Pharmaceuticals LP | $12.80 | 2021 | |
| Portola Pharmaceuticals, LLC | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhat Khairallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.